Management en optimalisatie van hemostase

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network

Bron‎: N Engl J Med 2017;376(2):136-48.

Geïndexeerd‎: PubMed 27774838

DOI‎: 10.1056/NEJMoa1606424

http://www.ncbi.nlm.nih.gov/pubmed/27774838 (opent nieuw venster)

Aprotinin for patients exposed to clopidogrel before off-pump coronary bypass. (opent nieuw venster)

Nurözler F, Kutlu T, Küçük G.

Bron‎: Asian Cardiovasc Thorac Ann 2008;16(6):483-7.

Geïndexeerd‎: PubMed 18984759

DOI‎: 10.1177/021849230801600611

https://www.ncbi.nlm.nih.gov/pubmed/18984759 (opent nieuw venster)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (opent nieuw venster)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Bron‎: JAMA Surg 2013;148(6):538-47.

Geïndexeerd‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (opent nieuw venster)

Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: The OPTIMAL randomized clinical trial. (opent nieuw venster)

Shi J, Zhou C, Pan W, Sun H, Liu S, Feng W, Wang W, Cheng Z, Wang Y, Zheng Z

Bron‎: JAMA. 2022;328(4):336-47.

Geïndexeerd‎: PubMed 35881121

DOI‎: 10.1001/jama.2022.10725

https://pubmed.ncbi.nlm.nih.gov/35881121/ (opent nieuw venster)

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. (opent nieuw venster)

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

Bron‎: Anesth Analg 2012;115(2):239-43.

Geïndexeerd‎: PubMed 21737704

DOI‎: 10.1213/ANE.0b013e3182264a11

https://www.ncbi.nlm.nih.gov/pubmed/21737704 (opent nieuw venster)

Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. (opent nieuw venster)

Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Hu S.

Bron‎: Ann Thorac Surg 2010;89(5):1489-95.

Geïndexeerd‎: PubMed 20417766

DOI‎: 10.1016/j.athoracsur.2010.02.006

https://www.ncbi.nlm.nih.gov/pubmed/20417766 (opent nieuw venster)

Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study. (opent nieuw venster)

Øvrum E, Tangen G, Tølløfsrud S, Ringdal MA, Øystese R, Istad R.

Bron‎: Interact Cardiovasc Thorac Surg 2010;10(4):545-8.

Geïndexeerd‎: PubMed 20067988

DOI‎: 10.1510/icvts.2009.226613

https://www.ncbi.nlm.nih.gov/pubmed/20067988 (opent nieuw venster)

Recombinante geactiveerde factor VII (rFVIIa)

Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa? (opent nieuw venster)

Ballen J, Raabe M, Muirhead B.

Bron‎: Can J Anaesth 2006;53(4):353-6.

Geïndexeerd‎: PubMed 16575032

DOI‎: 10.1007/BF03022498

https://www.ncbi.nlm.nih.gov/pubmed/16575032 (opent nieuw venster)

Use of recombinant activated factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. (opent nieuw venster)

Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.

Bron‎: Transfusion 2013;53(4):798-804.

Geïndexeerd‎: PubMed 22845023

DOI‎: 10.1111/j.1537-2995.2012.03801.x

https://www.ncbi.nlm.nih.gov/pubmed/22845023 (opent nieuw venster)

Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. (opent nieuw venster)

Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.

Bron‎: Ann Thorac Surg 2008;85(3):836-44.

Geïndexeerd‎: PubMed 18291152

DOI‎: 10.1016/j.athoracsur.2007.06.076

https://www.ncbi.nlm.nih.gov/pubmed/18291152 (opent nieuw venster)

Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia. (opent nieuw venster)

Elmistekawy E, Lapierre H, Bourke M, Dennie C, Labinaz M, Ruel M.

Bron‎: Can J Cardiol 2011;27(6):869.e7-8.

Geïndexeerd‎: PubMed 21983113

DOI‎: 10.1016/j.cjca.2011.07.632

https://www.ncbi.nlm.nih.gov/pubmed/21983113 (opent nieuw venster)

Off-label use of recombinant activated factor VII for cardiac surgical bleeding. (opent nieuw venster)

Flynn BC, Steiner ME, Mazzeffi M

Bron‎: Anesthesiology. 2023 1;139(2):197-210.

Geïndexeerd‎: PubMed 37155359

DOI‎: 10.1097/ALN.0000000000004569

https://pubmed.ncbi.nlm.nih.gov/37155359/ (opent nieuw venster)

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. (opent nieuw venster)

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

Bron‎: Circulation 2009;120(1):21-7.

Geïndexeerd‎: PubMed 19546387

DOI‎: 10.1161/CIRCULATIONAHA.108.834275

https://www.ncbi.nlm.nih.gov/pubmed/19546387 (opent nieuw venster)

Intraoperative use of recombinant activated factor VII during complex aortic surgery. (opent nieuw venster)

Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.

Bron‎: J Thorac Cardiovasc Surg 2012;143(5):1198-204.

Geïndexeerd‎: PubMed 22285329

DOI‎: 10.1016/j.jtcvs.2012.01.004

https://www.ncbi.nlm.nih.gov/pubmed/22285329 (opent nieuw venster)

Off-label use of recombinant human factor VIIa. (opent nieuw venster)

Goodnough LT, Levy JH.

Bron‎: Ann Thorac Surg 2014;98(2):393-5.

Geïndexeerd‎: PubMed 25087781

DOI‎: 10.1016/j.athoracsur.2014.06.007

https://www.ncbi.nlm.nih.gov/pubmed/25087781 (opent nieuw venster)

Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). (opent nieuw venster)

Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.

Bron‎: Eur J Cardiothorac Surg 2011;40(6):1320-7.

Geïndexeerd‎: PubMed 21550261

DOI‎: 10.1016/j.ejcts.2011.03.032

https://www.ncbi.nlm.nih.gov/pubmed/21550261 (opent nieuw venster)

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. (opent nieuw venster)

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Bron‎: Circulation 2008;118(4):331-8.

Geïndexeerd‎: PubMed 18606914

DOI‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 (opent nieuw venster)

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. (opent nieuw venster)

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

Bron‎: J Vasc Surg 2011;53(4):1032-7.

Geïndexeerd‎: PubMed 21215579

DOI‎: 10.1016/j.jvs.2010.07.075

https://www.ncbi.nlm.nih.gov/pubmed/21215579 (opent nieuw venster)

Use of activated recombinant factor VII in severe bleeding—evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding. (opent nieuw venster)

Lau P, Ong V, Tan WT, Koh PL, Hartman M.

Bron‎: Transfus Med Hemother 2012;39(2):139-50.

Geïndexeerd‎: PubMed 22670132

DOI‎: 10.1159/000338034

https://www.ncbi.nlm.nih.gov/pubmed/22670132 (opent nieuw venster)

Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection. (opent nieuw venster)

Lehr EJ, Alford TJ, Wang SH.

Bron‎: Heart Surg Forum 2010;13(5):E275-9.

Geïndexeerd‎: PubMed 20961825

DOI‎: 10.1532/HSF98.20101027

https://www.ncbi.nlm.nih.gov/pubmed/20961825 (opent nieuw venster)

Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. (opent nieuw venster)

Masud F, Bostan F, Chi E, Pass SE, Samir H, Stuebing K, Liebl MG.

Bron‎: J Cardiothorac Vasc Anesth 2009;23(1):28-33.

Geïndexeerd‎: PubMed 18948033

DOI‎: 10.1053/j.jvca.2008.08.003

https://www.ncbi.nlm.nih.gov/pubmed/18948033 (opent nieuw venster)

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery. (opent nieuw venster)

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM.

Bron‎: Drugs R D 2015;15(2):187-94.

Geïndexeerd‎: PubMed 25862216

DOI‎: 10.1007/s40268-015-0093-9

https://www.ncbi.nlm.nih.gov/pubmed/25862216 (opent nieuw venster)

Hemostatic management of severe thrombocytopenia in a patient undergoing pulmonic valve replacement. (opent nieuw venster)

Tanaka KA, Li P, McHugh SM, Subramaniam K.

Bron‎: A A Case Rep 2015;5(1):3-5.

Geïndexeerd‎: PubMed 26125690

DOI‎: 10.1213/XAA.0000000000000166

https://www.ncbi.nlm.nih.gov/pubmed/26125690 (opent nieuw venster)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (opent nieuw venster)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Bron‎: Anesthesiology 2003;98(6):1513-5.

Geïndexeerd‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (opent nieuw venster)

Recombinant activated factor VII in cardiac surgery: a systematic review. (opent nieuw venster)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Bron‎: Ann Thorac Surg 2007;83(2):707-14.

Geïndexeerd‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (opent nieuw venster)

Coagulatiefactorconcentraten

Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion. (opent nieuw venster)

Alberts M, Bandarenko N, Gaca J, Lockhart E, Milano C, Alexander S, Linder D, Lombard FW, Welsby IJ.

Bron‎: Transfusion 2014;54(5):1348-57.

Geïndexeerd‎: PubMed 24898456

DOI‎: 10.1111/trf.12463

https://www.ncbi.nlm.nih.gov/pubmed/24898456 (opent nieuw venster)

Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. (opent nieuw venster)

Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F.

Bron‎: Interact Cardiovasc Thorac Surg 2012;15(3):382-9.

Geïndexeerd‎: PubMed 22623627

DOI‎: 10.1093/icvts/ivs224

https://www.ncbi.nlm.nih.gov/pubmed/22623627 (opent nieuw venster)

Reducing blood transfusion in aortic surgery: a novel approach. (opent nieuw venster)

Birla R, Nawaytou O, Shaw M, Jackson A, Mills K, Kuduvalli M, Field M, Agarwal S

Bron‎: Ann Thorac Surg 2019;108(5):1369-75.

Geïndexeerd‎: PubMed 31255616

DOI‎: 10.1016/j.athoracsur.2019.04.127

https://www.ncbi.nlm.nih.gov/pubmed/31255616 (opent nieuw venster)

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. (opent nieuw venster)

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Bron‎: Ann Thorac Surg 2009;88(5):1666-8.

Geïndexeerd‎: PubMed 19853132

DOI‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 (opent nieuw venster)

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. (opent nieuw venster)

Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C.

Bron‎: Crit Care 2016;20:5.

Geïndexeerd‎: PubMed 26738468

DOI‎: 10.1186/s13054-015-1172-6

https://www.ncbi.nlm.nih.gov/pubmed/26738468 (opent nieuw venster)

Bloodless orthotopic heart transplantation in a Jehovah's Witness. (opent nieuw venster)

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

Bron‎: A A Case Rep 2015;4(10):140-2.

Geïndexeerd‎: PubMed 25974419

DOI‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 (opent nieuw venster)

State of the art - how I manage coagulopathy in cardiac surgery patients. (opent nieuw venster)

Davidson S.

Bron‎: Br J Haematol 2014;164(6):779-89.

Geïndexeerd‎: PubMed 24450971

DOI‎: 10.1111/bjh.12746

https://www.ncbi.nlm.nih.gov/pubmed/24450971 (opent nieuw venster)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (opent nieuw venster)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Bron‎: Anesthesiology 2011;115(6):1179-91.

Geïndexeerd‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (opent nieuw venster)

Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial. (opent nieuw venster)

Karkouti K, Bartoszko J, Grewal D, Bingley C, Armali C, Carroll J, Hucke HP, Kron A, McCluskey SA, Rao V, Callum J

Bron‎: JAMA Netw Open 2021;4(4):e213936.

Geïndexeerd‎: PubMed 33792729

DOI‎: 10.1001/jamanetworkopen.2021.3936

https://www.ncbi.nlm.nih.gov/pubmed/33792729 (opent nieuw venster)

Prothrombin complex concentrate vs frozen plasma for coagulopathic bleeding in cardiac surgery: the FARES-II multicenter randomized clinical trial. (opent nieuw venster)

Karkouti K, Callum JL, Bartoszko J, Tanaka KA, Knaub S, Brar S, Ghadimi K, Rochon A, Mullane D, Couture EJ, Lin Y, Harle C, Zeller M, Tran DTT, Solomon C, Rao V, Law M, Butt AL, Chen EP, Martins MR, Saha T, Shih AW, Vézina MC, Moussa F, Pereira Cezar Zamper R, Syed S, Buyukdere H, Werner S, Grewal D, Wong D, Vandyck KB, Tanzola R, Hughes B, Royer O, Wong S, Levy JH; FARES-II Study Group

Bron‎: JAMA 2025;333(20):1781-92.

Geïndexeerd‎: PubMed 40156829

DOI‎: 10.1001/jama.2025.3501

https://pubmed.ncbi.nlm.nih.gov/40156829/ (opent nieuw venster)

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. (opent nieuw venster)

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Bron‎: Thromb Haemost 2009;102(1):137-44.

Geïndexeerd‎: PubMed 19572078

DOI‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 (opent nieuw venster)

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. (opent nieuw venster)

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.

Bron‎: J Thorac Cardiovasc Surg 2013;145(3 Suppl):S178-85.

Geïndexeerd‎: PubMed 23410777

DOI‎: 10.1016/j.jtcvs.2012.12.083

https://www.ncbi.nlm.nih.gov/pubmed/23410777 (opent nieuw venster)

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. (opent nieuw venster)

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Bron‎: Anesthesiology 2013;118(1):40-50.

Geïndexeerd‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 (opent nieuw venster)

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. (opent nieuw venster)

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Bron‎: J Am Heart Assoc 2015;4(6):e002066.

Geïndexeerd‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 (opent nieuw venster)

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST). (opent nieuw venster)

Ranucci M, Baryshnikova E.

Bron‎: Br J Anaesth 2016;116(5):618-23.

Geïndexeerd‎: PubMed 26893405

DOI‎: 10.1093/bja/aev539

https://www.ncbi.nlm.nih.gov/pubmed/26893405 (opent nieuw venster)

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. (opent nieuw venster)

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Bron‎: Can J Anaesth 2012;59(3):299-303.

Geïndexeerd‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 (opent nieuw venster)

Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis. (opent nieuw venster)

Roman M, Biancari F, Ahmed AB, Agarwal S, Hadjinikolaou L, Al-Sarraf A, Tsang G, Oo AY, Field M, Santini F, Mariscalco G

Bron‎: Ann Thorac Surg 2019;107(4):1275-83.

Geïndexeerd‎: PubMed 30458156

DOI‎: 10.1016/j.athoracsur.2018.10.013

https://www.ncbi.nlm.nih.gov/pubmed/30458156 (opent nieuw venster)

Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. (opent nieuw venster)

Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA.

Bron‎: Anesth Analg 2007;104(4):763-5.

Geïndexeerd‎: PubMed 17377078

DOI‎: 10.1213/01.ane.0000250913.45299.f3

https://www.ncbi.nlm.nih.gov/pubmed/17377078 (opent nieuw venster)

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. (opent nieuw venster)

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

Bron‎: Scand J Clin Lab Invest 2012;72(2):121-8.

Geïndexeerd‎: PubMed 22233480

DOI‎: 10.3109/00365513.2011.643818

https://www.ncbi.nlm.nih.gov/pubmed/22233480 (opent nieuw venster)

Desmopressine

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. (opent nieuw venster)

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

Bron‎: Anaesthesia 2010;65(7):688-91.

Geïndexeerd‎: PubMed 20477783

DOI‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 (opent nieuw venster)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (opent nieuw venster)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Bron‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Geïndexeerd‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (opent nieuw venster)

Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults. (opent nieuw venster)

Wademan BH, Galvin SD.

Bron‎: Interact Cardiovasc Thorac Surg 2014;18(3):360-70.

Geïndexeerd‎: PubMed 24263581

DOI‎: 10.1093/icvts/ivt491

https://www.ncbi.nlm.nih.gov/pubmed/24263581 (opent nieuw venster)

A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. (opent nieuw venster)

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C.

Bron‎: Anesth Analg 2010;110(3):702-7.

Geïndexeerd‎: PubMed 20042444

DOI‎: 10.1213/ANE.0b013e3181c92a5c

https://www.ncbi.nlm.nih.gov/pubmed/20042444 (opent nieuw venster)

Topische hemostatica

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (opent nieuw venster)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Bron‎: Ann Surg 2010;251(2):217-28.

Geïndexeerd‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (opent nieuw venster)

A review of topical hemostatic agents for use in cardiac surgery. (opent nieuw venster)

Barnard J, Millner R.

Bron‎: Ann Thorac Surg 2009;88(4):1377-83.

Geïndexeerd‎: PubMed 19766855

DOI‎: 10.1016/j.athoracsur.2009.02.092

https://www.ncbi.nlm.nih.gov/pubmed/19766855 (opent nieuw venster)

Armentarium of topical hemostatic products in cardiovascular surgery: an update. (opent nieuw venster)

Forcillo J, Perrault LP.

Bron‎: Transfus Apher Sci 2014;50(1):26-31.

Geïndexeerd‎: PubMed 24412443

DOI‎: 10.1016/j.transci.2013.12.009

https://www.ncbi.nlm.nih.gov/pubmed/24412443 (opent nieuw venster)

A novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses. (opent nieuw venster)

Mani K, Campbell A, Fitzpatrick J, Modarai B, Carrell T, Rashid H, Zayed H.

Bron‎: Eur J Vasc Endovasc Surg 2013;45(1):51-6.

Geïndexeerd‎: PubMed 23134676

DOI‎: 10.1016/j.ejvs.2012.10.008

https://www.ncbi.nlm.nih.gov/pubmed/23134676 (opent nieuw venster)

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. (opent nieuw venster)

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Bron‎: Innovations (Phila) 2012;7(4):229-41.

Geïndexeerd‎: PubMed 23123988

DOI‎: 10.1097/IMI.0b013e3182747699

https://www.ncbi.nlm.nih.gov/pubmed/23123988 (opent nieuw venster)

Control of troublesome bleeding during repair of acute type A dissection with use of modified rapid deployment hemostat (MRDH). (opent nieuw venster)

Salerno TA, Gaughan C, Suarez M, Panos AL.

Bron‎: J Card Surg 2009;24(6):722-4.

Geïndexeerd‎: PubMed 20078720

DOI‎: 10.1111/j.1540-8191.2009.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/20078720 (opent nieuw venster)

Topical haemostatic agents. (opent nieuw venster)

Seyednejad H, Imani M, Jamieson T, Seifalian AM.

Bron‎: Br J Surg 2008;95(10):1197-225.

Geïndexeerd‎: PubMed 18763249

DOI‎: 10.1002/bjs.6357

https://www.ncbi.nlm.nih.gov/pubmed/18763249 (opent nieuw venster)

Visco-elastische tests ter vaststelling van chirurgische of coagulopathische bloedingen

An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. (opent nieuw venster)

Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W.

Bron‎: Transfus Med 2006;16(1):31-9.

Geïndexeerd‎: PubMed 16480437

DOI‎: 10.1111/j.1365-3148.2006.00645.x

https://www.ncbi.nlm.nih.gov/pubmed/16480437 (opent nieuw venster)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (opent nieuw venster)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Bron‎: Anesthesiology 2011;115(6):1179-91.

Geïndexeerd‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (opent nieuw venster)

Management of hemorrhage in cardiothoracic surgery. (opent nieuw venster)

Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA.

Bron‎: J Cardiothorac Vasc Anesth 2013;27(4 Suppl):S20-34.

Geïndexeerd‎: PubMed 23910533

DOI‎: 10.1053/j.jvca.2013.05.014

https://www.ncbi.nlm.nih.gov/pubmed/23910533 (opent nieuw venster)

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. (opent nieuw venster)

Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K.

Bron‎: Anesthesiology 2012;117(3):531-47.

Geïndexeerd‎: PubMed 22914710

DOI‎: 10.1097/ALN.0b013e318264c644

https://www.ncbi.nlm.nih.gov/pubmed/22914710 (opent nieuw venster)

Antifibrinolytica

Recombinante geactiveerde factor VII (rFVIIa)

Coagulatiefactorconcentraten

Desmopressine

Topische hemostatica

Visco-elastische tests ter vaststelling van chirurgische of coagulopathische bloedingen

Selecteer een taal